MASSIMI, ISABELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.400
EU - Europa 373
AS - Asia 207
AF - Africa 13
SA - Sud America 9
Totale 2.002
Nazione #
US - Stati Uniti d'America 1.387
IT - Italia 180
SG - Singapore 102
IN - India 50
SE - Svezia 45
FI - Finlandia 44
CN - Cina 39
BG - Bulgaria 28
DE - Germania 27
CA - Canada 13
IE - Irlanda 11
UA - Ucraina 11
TG - Togo 10
ID - Indonesia 9
GB - Regno Unito 8
AR - Argentina 7
AT - Austria 7
RO - Romania 3
CO - Colombia 2
DZ - Algeria 2
HK - Hong Kong 2
IR - Iran 2
JP - Giappone 2
LT - Lituania 2
NL - Olanda 2
RU - Federazione Russa 2
BE - Belgio 1
FR - Francia 1
LU - Lussemburgo 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 2.002
Città #
Fairfield 228
Ashburn 120
Chandler 118
Seattle 108
Houston 90
Rome 85
Woodbridge 84
Cambridge 80
Singapore 73
Wilmington 68
Dearborn 52
Santa Clara 48
San Paolo di Civitate 33
Princeton 31
Helsinki 26
Plano 25
Sofia 24
Fremont 22
Lawrence 22
Ann Arbor 19
Boston 19
Millbury 18
Beijing 17
New York 15
San Diego 14
Dublin 11
Milan 11
Lomé 10
Jakarta 9
Grafing 8
Andover 7
Federal 7
Toronto 7
Vienna 7
Washington 7
Falkenstein 6
Nanjing 6
Norwalk 5
Ottawa 5
Phoenix 5
Vignanello 4
Falls Church 3
Jacksonville 3
Mannheim 3
Pune 3
Redwood City 3
Aylesford 2
Bogotá 2
Buffalo 2
Bühl 2
Ercolano 2
Hong Kong 2
London 2
Los Angeles 2
Piemonte 2
Shinchiba 2
Stuttgart 2
Tremestieri Etneo 2
Amsterdam 1
Anzio 1
Ariccia 1
Baotou 1
Birmingham 1
Brentford 1
Brussels 1
Chennai 1
Chongqing 1
Civitavecchia 1
Clearwater 1
Fuzhou 1
Guildford 1
Jinan 1
Karaman 1
Kunming 1
Laurel 1
Luxembourg 1
Medesano 1
Montréal 1
Morlupo 1
Moscow 1
Muizenberg 1
Munich 1
Padova 1
Pavia 1
Prescot 1
San Cesareo 1
San Jose 1
San Mateo 1
Sandston 1
Shenyang 1
Syracuse 1
Tongling 1
Toulouse 1
Yellow Springs 1
Zhengzhou 1
Totale 1.630
Nome #
Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment 114
HMGB1-Induced Cross Talk between PTEN and miRs 221/222 in Thyroid Cancer 105
Impact of Multidrug Resistance Protein-4 Inhibitors on Modulating Platelet Function and High on-Aspirin Treatment Platelet Reactivity 104
Multidrug Resistance Protein-4 influences aspirin toxicity in human cell line 95
From human Megakaryocytes to platelets: Effects of aspirin on high-mobility group Box 1/receptor for advanced glycation end products axis 95
Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment 94
Action of HMGB1 on miR221/222 cluster in neuroblastoma cell lines 93
Nonsteroidal anti-inflammatory drugs in-vitro and in-vivo treatment and Multidrug Resistance Protein 4 expression in human platelets 93
Aspirin influences megakaryocytic gene expression leading to up-regulation of multidrug resistance protein-4 in human platelets 89
Platelet activation and multidrug resistance protein-4 expression in children and adolescents with different subtypes of primary thrombocythemia 89
MRP4 over-expression has a role on both reducing nitric oxide-dependent antiplatelet effect and enhancing ADP induced platelet activation 86
The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1 82
New platelet functional method for identification of pathogenic antibodies in HIT patients 80
Platelet miRNA-26b down-regulates multidrug resistance protein 4 in patients on chronic aspirin treatment 80
Aspirin-dependent effects on purinergic P2Y1 receptor express 80
Human papilloma virus-dependent HMGA1 expression is a relevant step in cervical carcinogenesis 78
Non-steroidal anti-inflammatory drugs increase MRP4 expression in an endometriotic epithelial cell line in a PPARa dependent manner 77
MiR-21 role in aspirin-dependent PPARα and MRP4 up-regulation 72
HMGA molecules in neuroblastic tumors 69
Molecular mechanism of HMGA1 deregulation in human neuroblastoma 66
MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness 66
Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention: Results of the ISAR-ASPI Registry 64
MYCN Sensitizes Human Neuroblastoma to Apoptosis by HIPK2 Activation through a DNA Damage Response 59
Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells 56
High mobility group Al is a molecular target for MYCN in human neuroblastoma 42
A functional interaction between TRPC/NCKX induced by DAG plays a role in determining calcium influx independently from PKC activation 38
null 29
Cilostazol reduces cerebrovascular risk through the inhibition of multi-drug resistance protein 4/ATP binding cassette subfamily C member 4 20
Totale 2.115
Categoria #
all - tutte 5.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.858


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020340 0 0 0 0 0 76 77 56 60 28 25 18
2020/2021214 13 15 22 55 5 23 0 10 28 36 5 2
2021/2022310 0 12 37 7 34 11 13 31 23 21 59 62
2022/2023350 55 88 19 30 49 36 1 19 31 1 15 6
2023/2024225 10 16 16 10 25 68 6 23 2 16 15 18
2024/2025176 13 49 12 37 35 30 0 0 0 0 0 0
Totale 2.115